Neuron Specific Enolase (NSE), Serum Test
Neuron Specific Enolase (NSE), Serum Test
Neuron Specific Enolase (NSE) is an enzyme found in neuronal and neuroendocrine cells. It serves as a biomarker for neuroendocrine tumors, small cell lung cancer (SCLC), and neuronal injury. The Neuron Specific Enolase (NSE), Serum Test measures NSE levels in the blood to aid in the diagnosis, prognosis, and monitoring of these conditions.
NSE is commonly elevated in conditions affecting the nervous system and certain cancers, making it a valuable tool in clinical practice. Elevated NSE levels may indicate neuroblastoma, small cell lung cancer, or central nervous system (CNS) disorders such as traumatic brain injury (TBI) and stroke.
Conditions associated with elevated NSE levels include Small Cell Lung Cancer (SCLC), Neuroblastoma, Carcinoid Tumors, Traumatic Brain Injury (TBI), Stroke and Hypoxic Brain Injury, and Neurodegenerative Disorders (e.g., Alzheimer's disease, Creutzfeldt-Jakob disease).
What is the Neuron Specific Enolase (NSE), Serum Test Used For?
This test is used to:
- Assist in diagnosing neuroendocrine tumors, including neuroblastoma and small cell lung cancer.
- Monitor treatment response in patients undergoing therapy for neuroendocrine malignancies.
- Evaluate neuronal damage in conditions such as traumatic brain injury, stroke, and hypoxic brain injury.
Differentiate between various neurological and oncological disorders.
Symptoms Suggesting the Need for an NSE Test
Loss of consciousness or coma (after head trauma or cardiac arrest)
Severe headache, dizziness, or confusion (stroke suspicion)
Sudden weakness or paralysis (one-sided body involvement)
Slurred speech, vision problems, or cognitive impairment\
Seizures or worsening epilepsy symptoms
Chronic cough, chest pain, difficulty breathing (lung cancer suspicion)
Unexplained weight loss, fatigue, night sweats
Hormonal imbalances (flushing, diarrhea, abnormal heart rate)
Preparation for the Test
No special preparation is required. A blood sample is drawn from a vein. Inform your doctor about any ongoing treatments or medications, as certain drugs may influence NSE levels.
Interpretation of Results
Normal (≤12 ng/mL)- No significant neurological or cancer-related concerns.
Moderately Elevated (12–25 ng/mL)- Could indicate minor neuronal injury, stroke, traumatic brain injury (TBI), or subclinical neuroendocrine tumor.
Significantly Elevated (>25 ng/mL) - Suggestive of small cell lung cancer (SCLC), neuroendocrine tumors, severe brain injury, or hypoxic-ischemic encephalopathy.
FAQs
Is the NSE test specific for cancer?
No, while NSE is elevated in neuroendocrine tumors, it is also found in brain injuries and neurodegenerative diseases.
Can NSE levels be used to track cancer progression?
Yes, serial NSE measurements help monitor treatment response and disease progression in neuroendocrine tumors.
Who should get an NSE test?
Individuals with suspected neuroendocrine tumors, neurological conditions, or traumatic brain injury may benefit from NSE testing.
What other tests are needed alongside NSE?
Additional tests like imaging (CT, MRI), chromogranin A, and synaptophysin levels may help confirm the diagnosis.
Can NSE levels fluctuate?
Yes, NSE levels may fluctuate due to hemolysis, metabolic stress, or ongoing treatment, requiring serial measurements for accuracy.
Related tests
Tests At Lupin Diagnostics